Literature DB >> 9617789

Pattern of brain destruction in Parkinson's and Alzheimer's diseases.

H Braak1, E Braak, D Yilmazer, R A de Vos, E N Jansen, J Bohl.   

Abstract

Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common age-related degenerative disorders of the human brain. Both diseases involve multiple neuronal systems and are the consequences of cytoskeletal abnormalities which gradually develop in only a small number of neuronal types. In AD, susceptible neurons produce neurofibrillary tangles (NFTs) and neuropil threads (NTs), while in PD, they develop Lewy bodies (LBs) and Lewy neurites (LNs). The specific lesional pattern of both illnesses accrues slowly over time and remains remarkably consistent across cases. In AD, six developmental stages can be distinguished on account of the predictable manner in which the neurofibrillary changes spread across the cerebral cortex. The pathologic process commences in the transentorhinal region (clinically silent stages I and II), then proceeds into adjoining cortical and subcortical components of the limbic system (stages III and IV - incipient AD), and eventually extends into association areas of the neocortex (stages V and VI - fully developed AD). During the course of PD, important components of the limbic system undergo specific lesions as well. The predilection sites include the entorhinal region, the CA2-sector of the hippocampal formation, the limbic nuclei of the thalamus, anterior cingulate areas, agranular insular cortex (layer VI), and - within the amygdala - the accessory cortical nucleus, the ventromedial divisions both of the basal and accessory basal nuclei, and the central nucleus. The amygdala not only generates important projections to the prefrontal association areas but also exerts influence upon all non-thalamic nuclei which in a non-specific manner project upon the cerebral cortex and upon the nuclei regulating endocrine and autonomic functions. All these amygdala-dependent structures themselves exhibit severe PD-specific lesions. In general, the extranigral destructions are in themselves not sufficient to produce overt intellectual deterioration. Similarly, AD-related pathology up to stage III may be asymptomatic as well. Fully developed PD with concurring incipient AD, however, is likely to cause impaired cognition. Presently available data support the view that the occurrence of additional lesions in the form of AD stage III (or more) destruction is the most common cause of intellectual decline in PD.

Entities:  

Mesh:

Year:  1996        PMID: 9617789     DOI: 10.1007/BF01276421

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  83 in total

1.  Neuronal inclusions of Parkinson's disease.

Authors:  W R Gibb; T Scott; A J Lees
Journal:  Mov Disord       Date:  1991       Impact factor: 10.338

2.  The primate mediodorsal (MD) nucleus and its projection to the frontal lobe.

Authors:  P S Goldman-Rakic; L J Porrino
Journal:  J Comp Neurol       Date:  1985-12-22       Impact factor: 3.215

Review 3.  Nigral and extranigral pathology in Parkinson's disease.

Authors:  H Braak; E Braak; D Yilmazer; C Schultz; R A de Vos; E N Jansen
Journal:  J Neural Transm Suppl       Date:  1995

Review 4.  Neuroanatomy of memory.

Authors:  S Zola-Morgan; L R Squire
Journal:  Annu Rev Neurosci       Date:  1993       Impact factor: 12.449

5.  Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains.

Authors:  M S Airaksinen; A Paetau; L Paljärvi; K Reinikainen; P Riekkinen; R Suomalainen; P Panula
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

6.  The hypothalamus in Parkinson disease.

Authors:  J W Langston; L S Forno
Journal:  Ann Neurol       Date:  1978-02       Impact factor: 10.422

7.  Tau and ubiquitin in the human hypothalamus in aging and Alzheimer's disease.

Authors:  D F Swaab; I Grundke-Iqbal; K Iqbal; H P Kremer; R Ravid; J A van de Nes
Journal:  Brain Res       Date:  1992-09-11       Impact factor: 3.252

8.  Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.

Authors:  T Arendt; V Bigl; A Arendt; A Tennstedt
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

9.  Degeneration of the intrahippocampal routes of the perforant and alvear pathways in senile dementia of Alzheimer type.

Authors:  T Mizutani; M Kashara
Journal:  Neurosci Lett       Date:  1995-01-23       Impact factor: 3.046

10.  A histamine-containing neuronal system in human brain.

Authors:  P Panula; M S Airaksinen; U Pirvola; E Kotilainen
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

View more
  60 in total

1.  Smoking and dementia in male British doctors: prospective study.

Authors:  R Doll; R Peto; J Boreham; I Sutherland
Journal:  BMJ       Date:  2000-04-22

2.  Neuropathology in mice expressing human alpha-synuclein.

Authors:  H van der Putten; K H Wiederhold; A Probst; S Barbieri; C Mistl; S Danner; S Kauffmann; K Hofele; W P Spooren; M A Ruegg; S Lin; P Caroni; B Sommer; M Tolnay; G Bilbe
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

3.  Activation of Glycogen Synthase Kinase-3 Mediates the Olfactory Deficit-Induced Hippocampal Impairments.

Authors:  Juan Hu; He-Zhou Huang; Xiang Wang; Ao-Ji Xie; Xiong Wang; Dan Liu; Jian-Zhi Wang; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2014-11-05       Impact factor: 5.590

Review 4.  Functional neuroanatomy of amygdalohippocampal interconnections and their role in learning and memory.

Authors:  Alexander J McDonald; David D Mott
Journal:  J Neurosci Res       Date:  2016-02-14       Impact factor: 4.164

5.  The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs.

Authors:  V Pedersen; W J Schmidt
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

6.  Electrophysiological evidence for visuocognitive dysfunction in younger non Caucasian patients with Parkinson's disease.

Authors:  L Sagliocco; F Bandini; M Pierantozzi; Z Mari; A Tzelepi; C Ko; J Gulzar; I Bodis-Wollner
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain.

Authors:  Atsushi Aoyagi; Carlo Condello; Jan Stöhr; Weizhou Yue; Brianna M Rivera; Joanne C Lee; Amanda L Woerman; Glenda Halliday; Sjoerd van Duinen; Martin Ingelsson; Lars Lannfelt; Caroline Graff; Thomas D Bird; C Dirk Keene; William W Seeley; William F DeGrado; Stanley B Prusiner
Journal:  Sci Transl Med       Date:  2019-05-01       Impact factor: 17.956

8.  α-Synuclein as a Biomarker for Parkinson's Disease: A Gut Feeling.

Authors:  Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2016-07-21

9.  Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.

Authors:  Kwangsik Nho; Shannon L Risacher; Paul K Crane; Charles DeCarli; M Maria Glymour; Christian Habeck; Sungeun Kim; Grace J Lee; Elizabeth Mormino; Shubhabrata Mukherjee; Li Shen; John D West; Andrew J Saykin
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

10.  Drug Targeting of alpha-Synuclein Oligomerization in Synucleinopathies.

Authors:  Tiago Fleming Outeiro; Aleksey Kazantsev
Journal:  Perspect Medicin Chem       Date:  2008-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.